Target intelligence / Profile preview

Serotonin transporter; Norepinephrine transporter (SERT (for serotonin transporter); NET (for norepinephrine transporter))

Target
SERT (for serotonin transporter); NET (for norepinephrine transporter)
Molecular classification
Transporter, Monoamine transporter, Solute carrier family (SLC6)
01

Overview

The serotonin transporter (SERT, encoded by SLC6A4) and the norepinephrine transporter (NET, also called noradrenaline transporter, encoded by SLC6A2) are integral membrane proteins of the solute carrier family 6. They are monoamine transporters responsible for the reuptake of serotonin and norepinephrine, respectively, from the synaptic cleft back into presynaptic neurons, thus terminating neurotransmitter action and regulating neurotransmitter levels in the central nervous system. Both are important therapeutic targets in the treatment of depression, anxiety disorders, ADHD, and other neuropsychiatric and neurological illnesses. Drugs targeting these transporters can increase neurotransmitter concentrations in the synaptic cleft, thereby enhancing their effects. The activity and regulation of these transporters are critical for normal synaptic signaling, and genetic variability may affect disease susceptibility and treatment response[1][2][3][4][5][6]. **Note:** - The original query asked for "Serotonin Transporter and Noradrenaline Transporter" as a single target. However, these are distinct proteins, each encoded by different genes, with different primary ligands (serotonin vs. norepinephrine) and biological roles. Therefore, the entry as a single combined target is *incorrect* for most structured pharmacological reference systems. These should be treated as two separate canonical entries: Serotonin transporter (SERT) and Norepinephrine transporter (NET). - For structured use, split or provide separate data for each[1][2][3][4][6].

Other names
SERT5-HTTSolute carrier family 6 member 4 (for serotonin transporter)NETNATSolute carrier family 6 member 2 (for norepinephrine transporter)
02

Mechanism of action

Inhibition of serotonin reuptake (SERT blockers increase synaptic serotonin) [3] Inhibition of norepinephrine reuptake (NET blockers increase synaptic norepinephrine) [1][2] Dual inhibition (SNRIs inhibit both SERT and NET) [6] Modulation of transporter expression or function through phosphorylation or drug exposure [5]

03

Biological functions

Neurotransmitter reuptakeRegulation of synaptic neurotransmitter concentrationTermination of neurotransmitter action
04

Disease associations

DepressionAnxiety disordersAttention-deficit/hyperactivity disorder (ADHD)Obsessive-compulsive disorder (OCD)Neurodegenerative disease
05

Safety considerations

Sexual dysfunction (SSRIs)Hypertension (SNRIs, stimulants)Risk of serotonin syndrome (combination therapies)Withdrawal symptomsPotential for abuse (psychostimulants, some antidepressants)Increased risk of suicidal thoughts (especially in young people)
06

Interacting drugs

Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, sertraline) [3]

5 more in the full profile.

07

Biomarkers

SLC6A4 gene promoter polymorphism (serotonin transporter)SLC6A2 gene polymorphisms (norepinephrine transporter)Platelet SERT levels for monitoring serotonergic function [3]

Beyond the preview

Go deeper on Serotonin transporter; Norepinephrine transporter (SERT (for serotonin transporter); NET (for norepinephrine transporter)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serotonin transporter; Norepinephrine transporter (SERT (for serotonin transporter); NET (for norepinephrine transporter)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call